DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Evaluating R/R DLBCL Outcomes With Rituximab Therapy Jul 22, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma DRG Variations in DLBCL: Validation and Prognostic Implications Jul 19, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Targeting PDK4 to Overcome Rituximab Resistance in DLBCL Jul 17, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma β2M as a Prognostic Marker in DLBCL: NCCN-IPI Integration Jul 12, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ViPOR Shows Promise in Relapsed DLBCL With Durable Remissions Jul 12, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) 1H MRS: A Potential Tool for Assessing BTK Inhibition Effects in MCL Jul 11, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma VCAN, CD3G, C1QB Influence on DLBCL Prognosis & Drug Sensitivity Jul 10, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Bendamustine: Safe Lymphodepletion Alternative in R/R LBCL Jul 04, 2024
